182
Views
28
CrossRef citations to date
0
Altmetric
Original Research

In vivo SELEX of bone targeting aptamer in prostate cancer bone metastasis model

, , , , , , & show all
Pages 149-159 | Published online: 21 Dec 2018

References

  • SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
  • BonapaceLCoissieuxMMWyckoffJMertzKDVargaZJuntTBentires-AljMCessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesisNature2014515752513013325337873
  • LluchACuevaJRuiz-BorregoMPonceJPérez-FidalgoJAZoledronic acid in the treatment of metastatic breast cancerAnticancer Drugs20142511724100278
  • CasasALlombartAMartínMDenosumab for the treatment of bone metastases in advanced breast cancerBreast201322558559223759273
  • KangYSiegelPMShuWA multigenic program mediating breast cancer metastasis to boneCancer Cell20033653754912842083
  • YinJJSelanderKChirgwinJMTGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases developmentJ Clin Invest199910321972069916131
  • EckhardtBLFrancisPAParkerBSAndersonRLStrategies for the discovery and development of therapies for metastatic breast cancerNat Rev Drug Discov201211647949722653217
  • HongCANamYSFunctional nanostructures for effective delivery of small interfering RNA therapeuticsTheranostics20144121211123225285170
  • MieleESpinelliGPMieleEDi FabrizioEFerrettiETomaoSGulinoANanoparticle-based delivery of small interfering RNA: challenges for cancer therapyInt J Nanomedicine201273637365722915840
  • DangLLiuJLiFTargeted delivery systems for molecular therapy in skeletal disordersInt J Mol Sci201617342844327011176
  • SunHZuYAptamers and their applications in nanomedicineSmall201511202352236425677591
  • LiangCGuoBWuHAptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategyNat Med201521328829425665179
  • CowinSCCardosoLBlood and interstitial flow in the hierarchical pore space architecture of bone tissueJ Biomech201548584285425666410
  • BlancoEShenHFerrariMPrinciples of nanoparticle design for overcoming biological barriers to drug deliveryNat Biotechnol201533994195126348965
  • CarmelietPAngiogenesis in life, disease and medicineNature2005438707093293616355210
  • FukumuraDJainRKTumor microvasculature and microenvironment: targets for anti-angiogenesis and normalizationMicrovasc Res2007742–3728417560615
  • MiJRayPLiuJIn vivo selection against human colorectal cancer xenografts identifies an aptamer that targets RNA helicase protein DHX9Mol Ther Nucleic Acids20165e31527115840
  • FolkmanJToward an understanding of angiogenesis: search and discoveryPerspect Biol Med198529110362415913
  • KerbelRSInhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agentsBioessays199113131361722975
  • FolkmanJAngiogenesis in cancer, vascular, rheumatoid and other diseaseNat Med19951127307584949
  • IngberDFujitaTKishimotoSSynthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature199034863015555571701033
  • KimKJLiBWinerJArmaniniMGillettNPhillipsHSFerraraNInhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature199336264238418447683111
  • O’ReillyMSHolmgrenLShingYAngiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinomaCell19947923153287525077
  • BrekkenRAOverholserJPStastnyVAWaltenbergerJMinnaJDThorpePESelective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in miceCancer Res200060185117512411016638
  • IshidaTKunduRKYangEHirataKHoYDQuertermousTTargeted disruption of endothelial cell-selective adhesion molecule inhibits angiogenic processes in vitro and in vivoJ Biol Chem200327836345983460412819200
  • AirdWCEndothelial cell heterogeneityCold Spring Harb Perspect Med201221a00642922315715